Back
abrdn Life Sciences Investors Vs. Ingevity Industry Stock Comparison
Sell
27
HQL
abrdn Life Sciences Investors
Last Price:
14.96
Seasonality Move:
0.6%
Sell
1
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Sell
27
abrdn Life Sciences Investors (HQL)
is a Sell
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
- The current abrdn Life Sciences Investors [HQL] share price is $14.80. The Score for HQL is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- HQL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $33.06. The Score for NGVT is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $14.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing selling pressure, which indicates risk of future bearish movement.
NGVT Stock Price Chart
HQL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 38.56 | Sell |
| Chaikin Money Flow: | -57007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.86 - 15.38) | Sell |
| Bollinger Bands (100): | (13.96 - 15.4) | Buy |
NGVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 34.38 | Sell |
| Chaikin Money Flow: | -258474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.39 - 40.21) | Sell |
| Bollinger Bands (100): | (36.97 - 47.79) | Sell |
HQL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.04 | Sell |
| 20-day SMA: | 15.16 | Sell |
| 50-day SMA: | 15.21 | Sell |
| 200-day SMA: | 14.15 | Buy |
| 8-day EMA: | 15.03 | Sell |
| 20-day EMA: | 15.13 | Sell |
| 50-day EMA: | 15.06 | Sell |
| 200-day EMA: | 14.3 | Buy |
NGVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.45 | Sell |
| 20-day SMA: | 37.7 | Sell |
| 50-day SMA: | 38.26 | Sell |
| 200-day SMA: | 44.33 | Sell |
| 8-day EMA: | 37.5 | Sell |
| 20-day EMA: | 38.02 | Sell |
| 50-day EMA: | 39.02 | Sell |
| 200-day EMA: | 43.99 | Sell |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
abrdn Life Sciences Investors Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ingevity Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||